Is Biocardia Inc (BCDA) overvalued? · $14.4M cap
Biocardia Inc (BCDA) is a biotechnology company listed on NASDAQ.
This page asks whether Biocardia Inc (BCDA) looks expensive on cached numbers — not a short thesis.
No cached income statement for BCDA, so there is no earnings base to call rich or cheap.
BCDA currently screens at market cap $14.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next BCDA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the BCDA stock page for the full model, not this heading.
Not investment advice.